The distribution and expression of claudin-5 and occludin at the rat blood-optic nerve barrier after borneol treatment.
The purpose of this study is to investigate the distribution and expression of the tight junction membrane proteins, claudin-5 and occludin, in rat blood-optic nerve barrier after borneol treatment. Seventy-two female Wistar rats were randomly divided into the borneol gastric lavage group and the equal volume solvent gastric lavage control group. The bilateral optic nerve from the retrobulbar region to the optic chiasma was collected from the rats in the two groups before gastric lavage and at 30 min, 1, 2, 4, and 8 h after gastric lavage. The distribution and expression of claudin-5 and occludin were detected using immunofluorescence staining, Western blotting, and reverse transcription polymerase chain reaction (RT-PCR). Results showed that claudin-5 translocated from the cell membrane to the cytoplasm at 30 min following initiation of borneol treatment, and this translocation peaked at 1 h. During this period of time, a small amount of occludin also translocated from the cell membrane to the cytoplasm. Four hours after initiation of treatment, claudin-5 and occludin levels in the cytoplasm began to decrease and were restored to their normal pattern 8 h after initiation of treatment. There were no significant differences in the levels of claudin-5 or occludin before or after treatment in either group. It was concluded that claudin-5 and occludin translocate within cells of the rat blood-optic nerve barrier after borneol treatment, and this translocation was reversible. Claudin-5 may play a potential role in permeability of the blood-optic nerve barrier following borneol treatment.
Jin
Di
D
Department of Ophthalmology, The First Affiliated Hospital of Harbin Medical University, No.23 Youzheng Street, Harbin, 150001, China.
Wang
Feng
F
Qu
Lijun
L
Li
Zhituo
Z
Jin
Lianhong
L
Liu
Ping
P
Xu
Xiaolin
X
Cui
Hao
H
D000818:Animals; D001812:Blood-Brain Barrier; D049428:Blood-Nerve Barrier; D001892:Camphanes / Q000627:therapeutic use*; D062507:Claudin-5; D005260:Female; D005751:Gastric Lavage; D005786:Gene Expression Regulation; D008565:Membrane Proteins / Q000096:biosynthesis* / Q000378:metabolism; D062793:Occludin; D009900:Optic Nerve / Q000473:pathology*; D051381:Rats; D017208:Rats, Wistar; D012997:Solvents / Q000737:chemistry; D019108:Tight Junctions / Q000378:metabolism
D001892:Camphanes; D062507:Claudin-5; C491510:Cldn5 protein, rat; D008565:Membrane Proteins; D062793:Occludin; C568987:Ocln protein, rat; D012997:Solvents; C022871:isoborneol
Zhongguo Yao Li Xue Bao. 1990 Jan;11(1):42-4
2403013
Trends Neurosci. 2001 Dec;24(12):719-25
11718877
Drug Metab Dispos. 1994 Jan-Feb;22(1):99-105
8149897
J Am Soc Nephrol. 1999 Jun;10(6):1337-45
10361874
Zhong Yao Cai. 2004 Dec;27(12):937-9
15807248
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2004 Jul;24(7):632-4
15307705
J Cell Biol. 1993 Dec;123(6 Pt 2):1777-88
8276896
J Neuroimmunol. 2006 Apr;173(1-2):45-55
16406118
Vascul Pharmacol. 2002 Jun;38(6):323-37
12529927
Exp Cell Res. 2004 Oct 15;300(1):202-12
15383327
Exp Cell Res. 2003 Nov 1;290(2):275-88
14567987
Graefes Arch Clin Exp Ophthalmol. 2010 Jan;248(1):59-63
19816703
Eur J Cell Biol. 2000 Oct;79(10):707-17
11089919
Adv Drug Deliv Rev. 2001 Mar 1;46(1-3):247-79
11259843
Prog Neurobiol. 2002 Dec;68(5):311-23
12531232
J Cell Biol. 2002 Mar 18;156(6):1099-111
11889141
J Comp Neurol. 1966 Jan;126(1):109-21
4956780
J Cell Biol. 1999 Dec 13;147(6):1351-63
10601346